Copy Link Print Information

Sovipostobart

(Synonyms: BMS-986249)
고객리뷰

Based on 1 Customer Validation

Sovipostobart is an immunoglobulin G1-kappa, anti-CTLA-4 human monoclonal antibody with cleavable prodomain. Sovipostobart is an immunostimulant and antineoplastic.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Purity: 96.528%
  • CAS No.: 2649371-19-5
  • 분자량:153.531 kDa
  • 보관:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Sovipostobart
  • Experimental Validation Results for Sovipostobart
  • Experimental Validation Results for Sovipostobart
  • Sovipostobart Chemical Structure
    Sovipostobart Chemical Structure
CAS No.: 2649371-19-5
사이즈
가격
재고
수량
Amount: USD 0.00
Please select quantity
or
or

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Sovipostobart Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
주변의 대리점 찾기 Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • 순도&문서
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

견적 받기 해외재고보유

Other size
견적 받기
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress 로그인
Register
Sign in to MedChemExpress
회원가입

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized CTLA-4 Protein, Human (HEK293, HY-P72959) can bind Sovipostobart. The EC50 for this effect is 17.01 ng/mL.

  • 1/16

    Flow Cytometry analysis of Raji cells labelling CTLA4 (red) with Sovipostobart (anti-CTLA4) (HY-P990080). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Sovipostobart Chemical Structure
    1/16
  • Sovipostobart
  • Immobilized CTLA-4 Protein, Human (HEK293, HY-P72959) can bind Sovipostobart. The EC50 for this effect is 17.01 ng/mL.
  • Flow Cytometry analysis of Raji cells labelling CTLA4 (red) with Sovipostobart (anti-CTLA4) (HY-P990080). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).